title: Clotting Factor (Cf) Product Use And Same-Day Risk For Thrombotic Adverse Events (Tes), As Recorded In Large Health Care Database During 2008-2013 Study Period.
authors.affiliation: HealthCore Inc., Alexandria, VA, USA.
authors.forename: B F
authors.initials: BF
authors.lastname: Ekezue
authors.affiliation: HealthCore Inc., Alexandria, VA, USA.
authors.forename: G
authors.initials: G
authors.lastname: Sridhar
authors.affiliation: U. S. Federal Drug Administration, Silver Spring, MD, USA.
authors.forename: H S
authors.initials: HS
authors.lastname: Izurieta
authors.affiliation: U. S. Federal Drug Administration, Silver Spring, MD, USA.
authors.forename: R A
authors.initials: RA
authors.lastname: Forshee
authors.affiliation: HealthCore Inc., Alexandria, VA, USA.
authors.forename: N
authors.initials: N
authors.lastname: Selvam
authors.affiliation: U. S. Federal Drug Administration, Silver Spring, MD, USA.
authors.forename: M V
authors.initials: MV
authors.lastname: Ovanesov
authors.affiliation: U. S. Federal Drug Administration, Silver Spring, MD, USA.
authors.forename: N
authors.initials: N
authors.lastname: Jain
authors.affiliation: U. S. Federal Drug Administration, Silver Spring, MD, USA.
authors.forename: P D
authors.initials: PD
authors.lastname: Mintz
authors.affiliation: U. S. Federal Drug Administration, Silver Spring, MD, USA.
authors.forename: S A
authors.initials: SA
authors.lastname: Anderson
authors.affiliation: U. S. Federal Drug Administration, Silver Spring, MD, USA.
authors.forename: M
authors.initials: M
authors.lastname: Menis